TMC4
gene geneOn this page
Summary
TMC4 (transmembrane channel like 4, HGNC:22998) is a protein-coding gene on chromosome 19q13.42, encoding Voltage-gated chloride channel TMC4 (Q7Z404). Voltage-gated chloride channel involved in high-concentration salt taste sensation.
Enables voltage-gated chloride channel activity. Predicted to be involved in sensory perception of salty taste. Located in extracellular exosome.
Source: NCBI Gene 147798 — RefSeq curated summary.
At a glance
- GWAS associations: 12
- Clinical variants (ClinVar): 137 total
- MANE Select transcript:
NM_144686
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:22998 |
| Approved symbol | TMC4 |
| Name | transmembrane channel like 4 |
| Location | 19q13.42 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000167608 |
| Ensembl biotype | protein_coding |
| OMIM | 617181 |
| Entrez | 147798 |
Gene structure
Transcript identifiers
Ensembl transcripts: 26 — 19 protein_coding, 4 retained_intron, 2 protein_coding_CDS_not_defined, 1 nonsense_mediated_decay
ENST00000446291, ENST00000476013, ENST00000495398, ENST00000497518, ENST00000611183, ENST00000613492, ENST00000613723, ENST00000615945, ENST00000617472, ENST00000619895, ENST00000883973, ENST00000883974, ENST00000883975, ENST00000883976, ENST00000883977, ENST00000883978, ENST00000883979, ENST00000883980, ENST00000883981, ENST00000883982, ENST00000883983, ENST00000927552, ENST00000927553, ENST00000927554, ENST00000957112, ENST00000957113
RefSeq mRNA: 2 — MANE Select: NM_144686
NM_001145303, NM_144686
CCDS: CCDS12882, CCDS46174
Canonical transcript exons
ENST00000612564 — 0 exons
Expression profiles
Bgee: expression breadth ubiquitous, 134 present calls, max score 98.74.
FANTOM5 (CAGE): breadth broad, TPM avg 5.3131 / max 168.7729, expressed in 431 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 182596 | 4.9070 | 426 |
| 182597 | 0.2295 | 148 |
| 182595 | 0.1766 | 121 |
Top tissues by expression
134 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right uterine tube | UBERON:0001302 | 98.74 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 98.22 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 98.11 | gold quality |
| duodenum | UBERON:0002114 | 97.27 | gold quality |
| body of pancreas | UBERON:0001150 | 96.61 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 96.30 | gold quality |
| thyroid gland | UBERON:0002046 | 96.12 | gold quality |
| metanephros cortex | UBERON:0010533 | 96.06 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 95.77 | gold quality |
| pituitary gland | UBERON:0000007 | 94.92 | gold quality |
| rectum | UBERON:0001052 | 94.74 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 94.69 | gold quality |
| minor salivary gland | UBERON:0001830 | 94.52 | gold quality |
| gall bladder | UBERON:0002110 | 94.48 | gold quality |
| adenohypophysis | UBERON:0002196 | 94.16 | gold quality |
| prostate gland | UBERON:0002367 | 93.92 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 93.76 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 92.96 | gold quality |
| pancreas | UBERON:0001264 | 92.72 | gold quality |
| transverse colon | UBERON:0001157 | 92.12 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 91.65 | gold quality |
| small intestine | UBERON:0002108 | 91.59 | gold quality |
| kidney | UBERON:0002113 | 91.44 | gold quality |
| cortex of kidney | UBERON:0001225 | 91.16 | gold quality |
| fallopian tube | UBERON:0003889 | 91.02 | gold quality |
| body of stomach | UBERON:0001161 | 90.97 | gold quality |
| stomach | UBERON:0000945 | 90.23 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 89.58 | gold quality |
| esophagus mucosa | UBERON:0002469 | 88.09 | gold quality |
| lung | UBERON:0002048 | 87.97 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 11.98 |
| E-GEOD-99795 | no | 29.45 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
5 targeting TMC4, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3925-3P | 100.00 | 69.95 | 1237 |
| HSA-MIR-5683 | 99.36 | 68.59 | 2083 |
| HSA-MIR-320E | 97.49 | 65.96 | 865 |
| HSA-MIR-6808-3P | 94.13 | 65.24 | 516 |
| HSA-MIR-11400 | 94.03 | 67.12 | 81 |
Literature-anchored findings (GeneRIF, showing 2)
- Report no association between the TMC4 rs641738 variant and the development and severity of NAFLD in individuals of European descent. (PMID:26850495)
- This study explored the role of rs641738 C/T located in TMC4 exon 1 (p.Gly17Glu) and 500 bases- downstream of MBOAT7 gene (TMC4/MBOAT7), in the genetic risk for developing nonalcoholic fatty liver disease (NAFLD). No evidence was found of association between rs641738 and either NAFLD (Cochran-Armitage test for trend, p = 0.529) or the disease severity (p = 0.61). (PMID:29572551)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | tmc4 | ENSDARG00000031757 |
| mus_musculus | Tmc4 | ENSMUSG00000019734 |
| rattus_norvegicus | Tmc4 | ENSRNOG00000059741 |
| caenorhabditis_elegans | WBGENE00015177 | |
| caenorhabditis_elegans | WBGENE00020490 |
Paralogs (7): TMC5 (ENSG00000103534), TMC6 (ENSG00000141524), TMC2 (ENSG00000149488), TMC1 (ENSG00000165091), TMC8 (ENSG00000167895), TMC7 (ENSG00000170537), TMC3 (ENSG00000188869)
Protein
Protein identifiers
Voltage-gated chloride channel TMC4 — Q7Z404 (reviewed: Q7Z404)
Alternative names: Transmembrane channel-like protein 4
All UniProt accessions (4): A0A087WT65, A0A087WVI4, A0A087WXY6, C9JFU4
UniProt curated annotations — full annotation on UniProt →
Function. Voltage-gated chloride channel involved in high-concentration salt taste sensation. Depolarization induced by high NaCl concentration may trigger the activation of TMC4-mediated chloride influx into taste bud cells, helping the return to resting potential. Also allows permeation of organic anions including gluconate, but their current amplitudes at positive potentials are less than that of chloride. Involved in pH and temperature-dependent modulation of salty taste.
Subcellular location. Membrane.
Similarity. Belongs to the TMC family.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q7Z404-2 | 1 | yes |
| Q7Z404-1 | 2 | |
| Q7Z404-3 | 3 |
RefSeq proteins (2): NP_001138775, NP_653287* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR012496 | TMC_dom | Domain |
| IPR038900 | TMC | Family |
Pfam: PF07810
Catalyzed reactions (Rhea), 1 shown:
- chloride(in) = chloride(out) (RHEA:29823)
UniProt features (31 total): topological domain 10, transmembrane region 9, sequence conflict 4, splice variant 3, sequence variant 2, chain 1, region of interest 1, glycosylation site 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q7Z404-F1 | 79.05 | 0.39 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Glycosylation sites (1): 107
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 88 (showing top):
GOBP_INORGANIC_ANION_TRANSPORT, GOBP_CHLORIDE_TRANSPORT, SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN, SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP, NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN, IK3_01, GOBP_TRANSMEMBRANE_TRANSPORT, CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP, GOMF_VOLTAGE_GATED_MONOATOMIC_ANION_CHANNEL_ACTIVITY, GOMF_GATED_CHANNEL_ACTIVITY, GOMF_PASSIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY, GOMF_MONOATOMIC_ANION_CHANNEL_ACTIVITY, GOMF_VOLTAGE_GATED_CHLORIDE_CHANNEL_ACTIVITY, GOMF_MONOATOMIC_ANION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY, DODD_NASOPHARYNGEAL_CARCINOMA_DN
GO Biological Process (0):
GO Molecular Function (2): voltage-gated chloride channel activity (GO:0005247), mechanosensitive monoatomic ion channel activity (GO:0008381)
GO Cellular Component (3): plasma membrane (GO:0005886), extracellular exosome (GO:0070062), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| chloride channel activity | 1 |
| voltage-gated monoatomic anion channel activity | 1 |
| monoatomic ion channel activity | 1 |
| gated channel activity | 1 |
| membrane | 1 |
| cell periphery | 1 |
| extracellular vesicle | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
548 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TMC4 | MBOAT7 | Q96N66 | 815 |
| TMC4 | TM6SF2 | Q9BZW4 | 728 |
| TMC4 | PNPLA3 | Q9NST1 | 696 |
| TMC4 | HSD17B13 | Q7Z5P4 | 642 |
| TMC4 | MAP6D1 | Q9H9H5 | 474 |
| TMC4 | PAXBP1 | Q9Y5B6 | 461 |
| TMC4 | COMTD1 | Q86VU5 | 460 |
| TMC4 | DISP2 | A7MBM2 | 453 |
| TMC4 | DUS2 | Q9NX74 | 452 |
| TMC4 | LPCAT4 | Q643R3 | 444 |
| TMC4 | COPRS | Q9NQ92 | 442 |
| TMC4 | CAMK1G | Q96NX5 | 421 |
| TMC4 | HEATR4 | Q86WZ0 | 415 |
| TMC4 | PODXL2 | Q9NZ53 | 412 |
| TMC4 | MDN1 | Q9NU22 | 411 |
IntAct
6 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TMC4 | MARCHF6 | psi-mi:“MI:0914”(association) | 0.350 |
| TSPAN15 | TMEM223 | psi-mi:“MI:0914”(association) | 0.350 |
| LDLRAD1 | ZNF316 | psi-mi:“MI:0914”(association) | 0.350 |
| LYPD3 | NEMP1 | psi-mi:“MI:0914”(association) | 0.350 |
| FLT1 | MTCL2 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (31): TMC4 (Protein-RNA), TUSC5 (Two-hybrid), MS4A13 (Two-hybrid), ANO6 (Affinity Capture-MS), TPCN1 (Affinity Capture-MS), SLC4A2 (Affinity Capture-MS), ANO5 (Affinity Capture-MS), RBMXL1 (Affinity Capture-MS), SLC12A4 (Affinity Capture-MS), TMEM179B (Affinity Capture-MS), FZD2 (Affinity Capture-MS), PKD2 (Affinity Capture-MS), SLC12A6 (Affinity Capture-MS), NDRG3 (Affinity Capture-MS), MARCH6 (Affinity Capture-MS)
ESM2 similar proteins: A1L504, A2A6C4, A5D7M7, A6NH21, A8WCG0, B0BNG2, D3ZI76, E9PY61, J3QMI4, O15554, O75908, O77759, O89109, P0C8N6, P51811, Q14DK4, Q1HG43, Q3TD49, Q496Z4, Q49LS0, Q49LS1, Q49LS5, Q49LS8, Q5GH56, Q5GH64, Q5GH72, Q5PQL3, Q5T1A1, Q5XK03, Q60850, Q6PRD1, Q7RTS5, Q7RTS6, Q7TN58, Q7TN60, Q7TQ65, Q7Z403, Q7Z404, Q80SX5, Q80UF9
Diamond homologs: A0A0U1QT59, E7FFT2, F1QFU0, F1QZE9, Q32NZ6, Q496Z4, Q4R7U0, Q5M7W4, Q6UXY8, Q7TN58, Q7TQ65, Q7Z402, Q7Z404, Q8C428, Q8IU68, Q8R4P4, Q8R4P5, Q8TDI7, Q8TDI8, Q11069, Q5YCC5, D3KZG3
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
137 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 97 |
| Likely benign | 12 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2233 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:54160462:CTCA:C | donor_loss | 1.0000 |
| 19:54160463:TCA:T | donor_loss | 1.0000 |
| 19:54160464:CA:C | donor_loss | 1.0000 |
| 19:54160465:ACCG:A | donor_loss | 1.0000 |
| 19:54160466:CCGT:C | donor_gain | 1.0000 |
| 19:54162671:A:AC | donor_gain | 1.0000 |
| 19:54162672:C:CC | donor_gain | 1.0000 |
| 19:54162672:CTTT:C | donor_gain | 1.0000 |
| 19:54163029:TCACC:T | donor_loss | 1.0000 |
| 19:54163030:CA:C | donor_loss | 1.0000 |
| 19:54163031:A:AC | donor_gain | 1.0000 |
| 19:54163032:C:CC | donor_gain | 1.0000 |
| 19:54163155:CGGTC:C | acceptor_gain | 1.0000 |
| 19:54163156:GGTCC:G | acceptor_loss | 1.0000 |
| 19:54163160:C:CC | acceptor_gain | 1.0000 |
| 19:54164403:C:CA | donor_gain | 1.0000 |
| 19:54164411:T:TA | donor_gain | 1.0000 |
| 19:54165415:GCAC:G | donor_loss | 1.0000 |
| 19:54165418:CCT:C | donor_loss | 1.0000 |
| 19:54165562:CCGAG:C | acceptor_gain | 1.0000 |
| 19:54165563:CGAGC:C | acceptor_gain | 1.0000 |
| 19:54165564:GAG:G | acceptor_gain | 1.0000 |
| 19:54165565:AG:A | acceptor_gain | 1.0000 |
| 19:54165567:C:CC | acceptor_gain | 1.0000 |
| 19:54165567:CTG:C | acceptor_loss | 1.0000 |
| 19:54165568:T:A | acceptor_loss | 1.0000 |
| 19:54169518:T:TA | donor_gain | 1.0000 |
| 19:54169536:C:CA | donor_gain | 1.0000 |
| 19:54169562:T:TA | donor_gain | 1.0000 |
| 19:54169563:C:A | donor_gain | 1.0000 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000096184 (19:54170655 A>T), RS1000142983 (19:54161482 G>A), RS1000249856 (19:54167297 C>T), RS1000292410 (19:54173303 G>A,C,T), RS1000309888 (19:54172812 C>T), RS1000341988 (19:54172523 G>A), RS1000697066 (19:54171536 G>A), RS1001083684 (19:54173468 C>A), RS1001191748 (19:54167776 T>C), RS1001246921 (19:54161542 T>G), RS1001306327 (19:54173653 A>C), RS1001569486 (19:54173891 G>A), RS1002252855 (19:54173652 CAAGG>C), RS1002374668 (19:54163073 T>C), RS1002376684 (19:54162462 A>G)
Disease associations
OMIM: gene MIM:617181 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
12 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST008758_80 | Pre-treatment viral load in HIV-1 infection | 2.000000e-16 |
| GCST009652_31 | Serum alkaline phosphatase levels | 8.000000e-16 |
| GCST011353_4 | Serum alkaline phosphatase levels | 3.000000e-10 |
| GCST012020_545 | Serum metabolite levels | 2.000000e-14 |
| GCST012020_546 | Serum metabolite levels | 2.000000e-21 |
| GCST012020_547 | Serum metabolite levels | 2.000000e-13 |
| GCST012232_36 | Lipoprotein (a) levels | 7.000000e-10 |
| GCST90002398_94 | Neutrophil count | 1.000000e-09 |
| GCST90002400_97 | Plateletcrit | 6.000000e-23 |
| GCST90002402_572 | Platelet count | 1.000000e-18 |
| GCST90002407_636 | White blood cell count | 5.000000e-09 |
| GCST90013406_136 | Liver enzyme levels (alkaline phosphatase) | 3.000000e-59 |
EFO canonical traits (6, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0010125 | viral load |
| EFO:0004533 | alkaline phosphatase measurement |
| EFO:0006925 | lipoprotein A measurement |
| EFO:0004833 | neutrophil count |
| EFO:0007985 | platelet crit |
| EFO:0004309 | platelet count |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
PharmGKB variants
2 variants.
| Variant | Genes | Level | Score | #Clin annots | Drugs |
|---|---|---|---|---|---|
| rs626283 | MBOAT7, TMC4 | 0.00 | 0 | ||
| rs641738 | MBOAT7, TMC4 | 0.00 | 0 |
CTD chemical–gene interactions
28 total (human), top 28 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Calcitriol | affects cotreatment, increases expression | 2 |
| Nickel | decreases expression | 2 |
| Valproic Acid | increases expression, increases methylation | 2 |
| aristolochic acid I | increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| propionaldehyde | increases expression | 1 |
| diethyl phthalate | decreases expression, increases abundance | 1 |
| sodium arsenite | decreases expression | 1 |
| butyraldehyde | increases expression | 1 |
| tobacco tar | decreases expression | 1 |
| benzo(e)pyrene | decreases methylation | 1 |
| S-(1,2-dichlorovinyl)cysteine | decreases expression, decreases reaction | 1 |
| monoethyl phthalate | decreases expression, increases abundance | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Air Pollutants | affects expression, increases abundance | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Coumestrol | affects cotreatment, decreases expression | 1 |
| Estradiol | affects cotreatment, decreases expression | 1 |
| Hydrogen Peroxide | affects expression | 1 |
| Lipopolysaccharides | decreases expression, decreases reaction | 1 |
| Methapyrilene | decreases methylation | 1 |
| Ozone | affects expression, increases abundance | 1 |
| Silicon Dioxide | decreases expression | 1 |
| Smoke | decreases expression | 1 |
| Testosterone | affects cotreatment, increases expression | 1 |
| Tobacco Smoke Pollution | affects expression | 1 |
| Acrylamide | increases expression | 1 |
| S-Nitrosoglutathione | increases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_YA81 | IDG-HEK293T-TMC4-V5-OE | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.